People · Operator
Named in public records as an officer, director or promoter · active 2017–2019 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Elysium Therapeutics, Inc. | — | Biotechnology | Seed | $4.0M | $28.6M | 2017 |
Thomas E. Jenkins at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Thomas E. Jenkins on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Alex Gregory Sturmer | 1 | 1 |
| Thomas Gregory Jenkins | 1 | 1 |
| James Gregory Hackworth | 1 | 1 |
| Bob Gregory Rappaport | 1 | 1 |
| Kathy Gregory LaPorte | 1 | 1 |
| Carey Gregory Ng | 1 | 1 |
| Kathy E. LaPorte | 1 | 1 |
| Bob E. Rappaport | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.